Key result
CHW-led hypertension care with independent prescribing was non-inferior to nurse-led care for 12-month BP control.
Why the study?
Hypertension treatment coverage and control remain poor globally, and it was unknown whether community health workers can safely manage hypertension through independent prescribing and titration of antihypertensive therapy.
Does community health worker-led hypertension management with independent prescribing and titrating of amlodipine-hydrochlorothiazide maintain blood pressure control at 12 months compared to usual nurse-led facility-based care in adults with treated, controlled hypertension in rural Lesotho?
RCT (n=807)
Open-label
1:1 cluster-randomised
Yes
Does community health worker-led hypertension management with independent prescribing and titrating of amlodipine-hydrochlorothiazide maintain blood pressure control at 12 months compared to usual nurse-led facility-based care in adults with treated, controlled hypertension in rural Lesotho?
Answers are grounded in this paper and cite their sources.
Community health worker-led hypertension management with independent prescribing of amlodipine-hydrochlorothiazide is non-inferior to nurse-led facility-based care for maintaining blood pressure control at 12 months in rural Lesotho.
Background: Hypertension is the leading global cause of premature mortality, yet treatment coverage and control remain poor. Whether community health workers (CHWs) can safely manage hypertension, including independent prescribing and titrating of antihypertensive therapy, remains unknown. Methods: We conducted a pragmatic, cluster-randomised, open-label, non-inferiority trial in 103 villages in rural Lesotho. Adults with treated, controlled hypertension (<140/90 mmHg) were eligible. Villages were randomised 1:1 to CHW-led hypertension care, including independent prescribing and titrating of antihypertensive therapy (amlodipine-hydrochlorothiazide combination pill at 5/12·5mg or 10/25mg) with clinical decision support, or to usual nurse-led, facility-based care. The primary endpoint was blood pressure control at 12 months among all randomised participants except those who became pregnant during follow-up, with a non-inferiority margin of –10% absolute risk difference. The study is completed and registered with ClinicalTrials.gov (NCT05684055). Findings: Between September 08, 2023, and January 31, 2024, we enrolled 807 participants (417 in 51 control villages, 390 in 50 intervention villages; 2 empty clusters; mean age 64.4 years; 82·3% women). At 12 months, blood pressure was controlled in 300 of 386 (77·7%) participants in the intervention group and 303 of 412 (73·5%) participants in the control group; 9 participants were excluded due to pregnancy. The absolute risk difference was 5·1% (95% CI, –0·9 to 11·2), meeting the criterion for non-inferiority. Mean 12-month systolic and diastolic blood pressures were 122·5 and 78·7 mmHg in the intervention group and 123·6 and 79·4 mmHg in the control group. Serious adverse events were similar in the two groups, with no excess events attributed to the intervention. Interpretation: These findings support decentralised, community-based hypertension care with task-sharing to trained CHWs as a scalable strategy to expand access to long-term chronic disease management in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Gerber et al. (2026) conducted an RCT in Hypertension (n=807). Community health worker-led hypertension care with independent prescribing and titrating of amlodipine-hydrochlorothiazide combination pill vs. Usual nurse-led, facility-based care was evaluated on Blood pressure control (<140/90 mmHg) at 12 months (ARD 5.1%, 95% CI -0.9 to 11.2). CHW-led hypertension care with independent prescribing was non-inferior to nurse-led care for 12-month BP control.
Synapse has enriched 10 related papers. Consider them for comparative context: